JPS5646816A - Remedy for malignant tumor - Google Patents

Remedy for malignant tumor

Info

Publication number
JPS5646816A
JPS5646816A JP12334879A JP12334879A JPS5646816A JP S5646816 A JPS5646816 A JP S5646816A JP 12334879 A JP12334879 A JP 12334879A JP 12334879 A JP12334879 A JP 12334879A JP S5646816 A JPS5646816 A JP S5646816A
Authority
JP
Japan
Prior art keywords
cyclophosphamide
acid
remedy
malignant tumor
tramexamic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12334879A
Other languages
Japanese (ja)
Other versions
JPS6328046B2 (en
Inventor
Hidemasa Ogawa
Noriko Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP12334879A priority Critical patent/JPS5646816A/en
Publication of JPS5646816A publication Critical patent/JPS5646816A/en
Publication of JPS6328046B2 publication Critical patent/JPS6328046B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: A remedy for a malignant tumor having extremely improved inhibition against tumor multiplication, reducing side effects, obtained by blending cyclophosphamide as a carcinostatic with tramexamic acid.
CONSTITUTION: Cyclophosphamide(chemical name: 2-[bis(2-chloroethyl)-amino] tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxide hydrate) is used together with tramexamic acid, antiplasmin. In administration tranexamic acid is preferably applied after medication of cyclophosphamide. A dose of cyclophosphamide is 20W50mg/kg, and a dose of tranexamic acid is about 1.0W3.0g/kg. The presence of tranexmic acid specifically reduces the amount of cyclophosphamide to be used and lowers side effects extremely.
COPYRIGHT: (C)1981,JPO&Japio
JP12334879A 1979-09-26 1979-09-26 Remedy for malignant tumor Granted JPS5646816A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12334879A JPS5646816A (en) 1979-09-26 1979-09-26 Remedy for malignant tumor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12334879A JPS5646816A (en) 1979-09-26 1979-09-26 Remedy for malignant tumor

Publications (2)

Publication Number Publication Date
JPS5646816A true JPS5646816A (en) 1981-04-28
JPS6328046B2 JPS6328046B2 (en) 1988-06-07

Family

ID=14858334

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12334879A Granted JPS5646816A (en) 1979-09-26 1979-09-26 Remedy for malignant tumor

Country Status (1)

Country Link
JP (1) JPS5646816A (en)

Also Published As

Publication number Publication date
JPS6328046B2 (en) 1988-06-07

Similar Documents

Publication Publication Date Title
MY100900A (en) Substituted phenylsulfonyloxybenzimidazolecarbamates, processes for their preparation and their use as medicaments.
JPS5551020A (en) Remedy for rheumatism
JPS5767516A (en) Novel analgesic agent
JPS57109721A (en) Carcinostatic agent
JPS5646816A (en) Remedy for malignant tumor
JPS5543030A (en) Prophylactic and remedy for microbial infection disease
JPS56138110A (en) Suppository containing citric acid or salt thereof
JPS5257313A (en) Manufacture of micellar insuline emulsion preparations
DE3372756D1 (en) Substituted benzenesulfonic acid esters, preparation thereof and their use as medicaments
JPS5665816A (en) Acetylsalicylate pharmaceutical for injection
JPS5527107A (en) N-(2-ethylhexyl)-crotonylamide and carcinostatic substance containing the same
JPS5536454A (en) Novel immunosuppressive agent
JPS57193473A (en) Vitamin e linoleic acid ester
JPS5536453A (en) Novel immunosuppressive agent
JPS54132239A (en) Anti-tumor agent
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS5668672A (en) Novel 2-acetoxybenzamide derviative, its preparation, and pharmaceutical containing said derviative as effective component
JPS5569510A (en) Carcinostatic agent
JPS55167220A (en) Antitumor drug
JPS52130905A (en) Medicinal composition
JPS52130926A (en) Medicinal composition comprising pentazocine and salicylamide
JPS57106621A (en) Preventing agent and remedy for fish disease
JPS5675430A (en) Antiarteriosclerotic agent containing ethyl piperidylacetylaminobenzoate
JPS5695114A (en) Carcinostatic agent
JPS57175119A (en) Agent for removing cancer